Forget 1% from a Cash ISA: I’d pick up 5%+ from these 2 FTSE 100 dividend shares

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver significantly higher income returns than a Cash ISA in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While the interest rates on Cash ISAs may have increased in the last couple of years, the average return is around 1%. That’s well below the rate of inflation, and means that savers are receiving a negative real-terms return on their cash.

By contrast, it is possible to obtain a dividend yield in excess of 5% from these two FTSE 100 shares at the present time.

Although they may experience volatility due to Brexit and the prospect of a global trade war, there is scope for capital growth in the long run. As such, now could be the right time to buy them.

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) may have failed to raise its dividends per share in recent years, but the stock still has a dividend yield of around 5%. Furthermore, the changes it is making to its business model could improve its long-term earnings growth outlook. This may mean that it is able to raise dividends at a brisk pace.

The company’s decision to offload a number of its consumer healthcare brands in order to focus on its pharmaceutical operations could provide it with greater focus in what is expected to be a growing industry. An ageing world population, growth in the size of the world’s population and urbanisation are expected to lead to increasing demand across the pharmaceutical industry. This could catalyse the company’s financial prospects and increase its ability to pay a higher dividend.

Since GlaxoSmithKline’s financial performance is less correlated to the wider economy than many of its FTSE 100 peers, it could provide a degree of stability during what may prove to be a volatile period for the world economy. As a result, it may deliver capital growth alongside an impressive income stream.

Sainsbury’s

While GlaxoSmithKline may offer defensive appeal, Sainsbury’s (LSE: SBRY) faces an uncertain future. The retailer’s share price has declined by 44% in the last year, with investors apparently concerned about its prospects following the collapse of its proposed merger with Asda.

Although the supermarket sector is experiencing pressure from increasingly price-conscious consumers, the threat of no-frills operators such as Aldi and Lidl and technological change, Sainsbury’s could deliver a relatively appealing income return. The company has a dividend yield of around 6% from a shareholder payout which is covered 1.9 times by profit. And, with the company’s bottom line due to rise by 4% this year, dividend growth may even be on the agenda.

Certainly, Sainsbury’s could continue its recent share price decline. With a price-to-earnings (P/E) ratio of just 8.5, however, the stock appears to have a wide margin of safety. This could mean that it is able to provide capital growth through a stock price recovery alongside its income return. This could lead to a significantly higher total return when compared to the 1% offered on average by Cash ISAs.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Night Takeoff Of The American Space Shuttle
Growth Shares

How UK investors can get access to the $2trn SpaceX stock IPO TODAY

Investors in the UK can get exposure to space powerhouse SpaceX today via several investment trusts that trade on the…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

Down 23% from its highs, I’ve just bagged myself a FTSE 100 bargain!

Stephen Wright has seized the opportunity to buy shares in a FTSE 100 company with outstanding growth prospects at an…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

How to turn an empty ISA into £100 a month in passive income

Stephen Wright outlines how real estate investment trusts can help UK investors aim for £100 a month in passive income…

Read more »

Man riding the bus alone
Investing Articles

Down 23%! Should I buy Meta Platforms for my ISA or SIPP?

Meta stock looks undervalued after sliding steadily lower since last summer. But should I buy the social media giant for…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

£5,000 invested in Greggs shares 2 years ago is now worth…

Anyone who bought Greggs' shares two years ago will now be sitting on heavy losses. Is there potential for a…

Read more »

Investing Articles

10 days to the next stock market crash?

What happens to the stock market when the current ceasefire in the Middle East expires? And what should investors do…

Read more »

Middle-aged Caucasian woman deep in thought while looking out of the window
Investing Articles

How to try and double the State Pension with just £30 a week

By saving money each week and investing regularly, even someone without a lot of cash to spare can aim to…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

2 badly beaten-down small caps to consider for a £20,000 Stocks and Shares ISA

Ben McPoland highlights a pair of UK small caps that have sold off heavily, making them worth considering for a…

Read more »